Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms.

Creative Commons License

Köker I. H., Ünver N., Malya F. Ü., Uysal Ö., Keskin E., Şentürk H.

Clinical endoscopy, cilt.54, ss.113-121, 2021 (ESCI, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 54
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5946/ce.2020.083
  • Dergi Adı: Clinical endoscopy
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.113-121
  • Anahtar Kelimeler: Carcinoembryonic antigen, Malignancy, Pancreatic cysts, INTERNATIONAL CONSENSUS GUIDELINES, PANCREATIC CYSTS, DIAGNOSIS, MANAGEMENT, CEA, CLASSIFICATION, COMBINATION, PERFORMANCE, ACCURACY, FEATURES
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Background/Aims: The role of cyst fluid carcinoembryonic antigen (CEA) level in differentiating mucinous pancreatic cystic lesions (PCLs) is controversial. We investigated the role of cyst fluid CEA in differentiating low-risk (LR)-intraductal papillary mucinous neoplasms (IPMNs) from high-risk (HR)-IPMNs and LR-mucinous cystic neoplasms (MCNs).